EP06.02. Tertiary Lymphoid Structures Predict Clinical Outcomes of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Xinying Xue
Meta Tag
Speaker Xinying Xue
Topic Pathology & Biomarkers: Biomarkers for Immuno-oncology
prognostic value
tumor-associated tertiary lymphoid structures
resectable non-small cell lung cancer
preoperative neoadjuvant chemoimmunotherapy
neoadjuvant chemotherapy
H&E staining
inside tumor bed region
outside tumor bed region
multiplex immunohistochemistry
recurrence-free survival
Powered By